Sanders Morris Harris LLC Has $223,000 Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Sanders Morris Harris LLC cut its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 85.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 23,948 shares of the pharmacy operator's stock after selling 138,450 shares during the quarter. Sanders Morris Harris LLC's holdings in Walgreens Boots Alliance were worth $223,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of WBA. Charles Schwab Investment Management Inc. grew its holdings in shares of Walgreens Boots Alliance by 43.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator's stock worth $98,284,000 after buying an additional 3,329,857 shares in the last quarter. Altrius Capital Management Inc grew its stake in shares of Walgreens Boots Alliance by 76.6% during the 3rd quarter. Altrius Capital Management Inc now owns 440,483 shares of the pharmacy operator's stock worth $3,947,000 after acquiring an additional 190,996 shares in the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of Walgreens Boots Alliance by 23.4% in the third quarter. PNC Financial Services Group Inc. now owns 340,431 shares of the pharmacy operator's stock valued at $3,050,000 after purchasing an additional 64,586 shares during the last quarter. Sasco Capital Inc. CT lifted its position in shares of Walgreens Boots Alliance by 13.6% in the third quarter. Sasco Capital Inc. CT now owns 1,041,440 shares of the pharmacy operator's stock worth $9,331,000 after purchasing an additional 124,950 shares in the last quarter. Finally, Sunbelt Securities Inc. boosted its holdings in Walgreens Boots Alliance by 82.8% during the third quarter. Sunbelt Securities Inc. now owns 139,377 shares of the pharmacy operator's stock worth $1,249,000 after purchasing an additional 63,149 shares during the last quarter. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Price Performance

NASDAQ:WBA traded up $0.40 during trading hours on Thursday, hitting $12.93. The company's stock had a trading volume of 18,780,868 shares, compared to its average volume of 31,192,266. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $23.76. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. The stock has a fifty day simple moving average of $9.43 and a 200-day simple moving average of $9.83. The company has a market capitalization of $11.16 billion, a P/E ratio of -1.26, a PEG ratio of 1.55 and a beta of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts' consensus estimates of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm's quarterly revenue was up 7.6% compared to the same quarter last year. During the same period last year, the company posted $0.66 EPS. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.52 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, December 12th. Stockholders of record on Monday, November 18th were issued a dividend of $0.25 per share. The ex-dividend date was Monday, November 18th. This represents a $1.00 annualized dividend and a dividend yield of 7.73%. Walgreens Boots Alliance's dividend payout ratio (DPR) is presently -9.77%.

Analysts Set New Price Targets

WBA has been the topic of several research reports. Jefferies Financial Group decreased their price target on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a "hold" rating on the stock in a research note on Wednesday, October 23rd. Royal Bank of Canada raised their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a "sector perform" rating in a report on Wednesday. Bank of America lifted their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research report on Monday. Morgan Stanley reduced their price target on Walgreens Boots Alliance from $9.00 to $7.00 and set an "underweight" rating on the stock in a research report on Friday, October 11th. Finally, Barclays lifted their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an "underweight" rating in a report on Wednesday, October 16th. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $13.27.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.